ENVB Return on Tangible Equity | ENVERIC BIOSCIENCES, INC.

ENVERIC BIOSCIENCES, INC. (ENVB) Return on Tangible Equity

2026-06-30: Return Tang Equity -112.09%.
2026-03-31: Return Tang Equity -172.50%.
2025-12-31: Return Tang Equity -225.95%.
2025-09-30: Return Tang Equity -307.90%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-112.09%
2026-03-31	-172.50%
2025-12-31	-225.95%
2025-09-30	-307.90%
2025-06-30	-526.22%
2025-03-31	-256.82%
2024-12-31	-737.95%
2024-09-30	-272.75%
2024-06-30	-210.77%
2024-03-31	-248.70%
2023-12-31	-1158.74%
2023-09-30	-1167.91%
2023-06-30	-517.99%
2023-03-31	-191.40%
2022-12-31	-132.77%
2022-09-30	-247.73%
2022-06-30	-261.45%
2022-03-31	-225.09%
2021-12-31	-242.82%
2021-09-30	-140.13%
2021-06-30	-313.64%
2021-03-31	-261.80%
2020-12-31	56.58%
2020-09-30	10.49%
2020-06-30	7.04%
2020-03-31	10.04%
2019-12-31	15.51%
2019-09-30	364.83%
2019-06-30	198.71%
2019-03-31	205.93%
2018-12-31	86.33%
2018-09-30	-146.03%
2018-06-30	60.51%
2018-03-31	81.41%
2017-12-31	76.13%
2017-09-30	33.97%
2017-06-30	23.17%
2017-03-31	12.70%
2016-12-31	19.25%
2016-09-30	19.59%
2016-06-30	55.16%
2016-03-31	1.75%
2015-09-30	-17.94%
2015-06-30	2541.69%
2015-03-31	168.55%
2014-12-31	-9987.68%
2014-09-30	6010.93%
2014-06-30	4087.63%
2013-12-31	0.80%
2013-09-30	74.59%
2013-06-30	87.53%
2013-03-31	102.06%
2012-12-31	122.70%
2012-09-30	331.48%
2012-06-30	750.03%
2012-03-31	-5164.90%
2011-12-31	-732.82%
2011-09-30	-191.35%
2011-06-30	52.69%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-344.31%
2024-12-31	25872.05%
2023-12-31	-10960.09%
2022-12-31	-145.39%
2021-12-31	-242.82%
2020-12-31	56.58%
2019-12-31	15.51%
2018-12-31	86.33%
2017-12-31	76.13%
2016-12-31	51.25%
2014-12-31	869.13%
2013-12-31	0.80%
2012-12-31	122.70%
2011-12-31	-732.82%
2010-12-31	79.65%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Bolt Biotherapeutics, Inc. (BOLT)	United States	$0.007B	-0.26
SYNLOGIC, INC. (SYBX)	United States	$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)	United States	$0.007B	-0.97
CNS Pharmaceuticals, Inc. (CNSP)	United States	$0.007B
Ernexa Therapeutics Inc. (ERNA)	United States	$0.006B
Apimeds Pharmaceuticals US, Inc. (APUS)	United States	$0.008B
Pulmatrix, Inc. (PULM)	United States	$0.006B
InMed Pharmaceuticals Inc. (INM)		$0.008B	-0.65
Ensysce Biosciences, Inc. (ENSC)	United States	$0.008B	-0.37
EXICURE, INC. (XCUR)	United States	$0.008B	-1.54